מן הרשת 02.05.202116:08 Active surveillance of metastatic renal cell carcinoma Results from a prospective observational study (MaRCC) Uro Today
מן הרשת 02.05.202116:08 First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma A Systematic Review and Network Meta-analysis Uro Today
מן הרשת 02.05.202116:07 Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma Uro Today
מן הרשת 02.05.202116:06 JNCCN Study Finds Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer Uro Today
מן הרשת 02.05.202116:05 Radiation therapy for high-risk non-muscle invasive bladder cancer Systematic review and meta-analysis Uro Today
מן הרשת 02.05.202116:04 Clinical characterization of radiation-associated muscle-invasive bladder cancer Uro Today
מן הרשת 02.05.202116:02 Optimal Pathologic Response After Neoadjuvant Chemotherapy For Muscle-Invasive Bladder Cancer Results From A Global, Multi-Center Collaboration Uro Today
מן הרשת 02.05.202116:01 Defining Cisplatin Eligibility in Patients with Muscle-Invasive Bladder Cancer - Beyond the Abstract Uro Today
מן הרשת 14.02.202113:44 Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma Enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who had previously received platinum-based treatm NEJM
מן הרשת 13.12.202011:50 Higher Risk of Falls/Fractures With Androgen Receptor Inhibitors An increase in the risk of falling and fracturing bones was associated with the use of androgen receptor inhibitors (ARIs) for the treatment of prostate cancer, a systematic review and meta-analysis suggests Medscape
מן הרשת 13.12.202011:49 High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Study Can be considered low priority procedure during COVID-19 pandemic, researchers say Medpage Today
מן הרשת 13.12.202011:47 Molecular subtypes of fully resected clear cell renal cell carcinoma Molecular subtypes of fully resected clear cell renal cell carcinoma are prognostic for risk of relapse and may impact adjuvant treatment uroonco
מן הרשת 13.12.202011:46 Probiotic Supplementation Modulates Gut Microbiome and Clinical Outcome Cancer Medicine
מן הרשת 13.12.202011:44 Management and survival of patients with retroperitoneal recurrences following radical nephrectomy Results from a multi-institutional international datasets uroonco
מן הרשת 13.12.202011:43 Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review Uro Today